Series B - Prognos Health

Series B - Prognos Health

Investment Firm

Overview

Prognos Health creates a healthcare analytics platform that uses patient-level data to generate clinical insights.

Announced Date

Jun 17, 2013

Funding Type

Series B

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund is a early_stage_venture and private_equity firm.

Participant Investors

3

Investor Name
Participant InvestorMerck Global Health Innovation Fund
Participant InvestorSafeguard Scientifics
Participant InvestorMentorTech Ventures

Round Details and Background

Prognos Health raised $15000000 on 2013-06-17 in Series B

Prognos Health creates a healthcare analytics platform that uses patient-level data to generate clinical insights.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 04, 2023
Venture Round - Prognos Health
9-23.3M
Aug 18, 2011
Convertible Note - Prognos Health
1-745.0K
Jun 17, 2013
Series B - Prognos Health
3-15.0M
Nov 17, 2011
Series A - Prognos Health
3-7.0M

Recent Activity

There is no recent news or activity for this profile.